INTEKRIN
InteKrin Therapeutics is a clinical-stage, privately held BioPharma company focused on developing and commercializing breakthrough therapeutics for neuroendocrine, metabolic, and immune disorders. Diseases such as diabetes, metabolic syndrome, and cancer are increasingly in need of novel treatments that provide patients with better treatment alternatives and help to curb soaring healthcare costs. The company is in the process of in-licensing early- and late-stage compounds that have the potential to unlock the complex hormonal relationship between metabolism, insulin resistance, and obesity.
INTEKRIN
Industry:
Biotechnology Neuroscience Therapeutics
Founded:
2005-01-01
Address:
Los Altos, California, United States
Country:
United States
Website Url:
http://www.intekrin.com
Total Employee:
1+
Status:
Closed
Contact:
650-941-5501
Email Addresses:
[email protected]
Total Funding:
66.42 M USD
Technology used in webpage:
GoDaddy DNS GoDaddy Intermedia
Current Advisors List
Investors List
Asset Management Company
Asset Management Company investment in Venture Round - InteKrin
Asset Management Company
Asset Management Company investment in Venture Round - InteKrin
Asset Management Company
Asset Management Company investment in Series C - InteKrin
Amgen Ventures
Amgen Ventures investment in Series C - InteKrin
Vivo Capital
Vivo Capital investment in Series C - InteKrin
Skyline Ventures
Skyline Ventures investment in Series C - InteKrin
OrbiMed
OrbiMed investment in Series C - InteKrin
Asset Management Ventures (AMV)
Asset Management Ventures (AMV) investment in Series C - InteKrin
Sofinnova Investments
Sofinnova Investments investment in Series C - InteKrin
Sears Capital Management
Sears Capital Management investment in Series C - InteKrin
Official Site Inspections
http://www.intekrin.com
- Host name: 142.215.74.97.host.secureserver.net
- IP address: 97.74.215.142
- Location: Scottsdale United States
- Latitude: 33.6013
- Longitude: -111.8867
- Metro Code: 753
- Timezone: America/Phoenix
- Postal: 85260
